NOMOGRAM FOR ESTIMATING CREATININE CLEARANCE

被引：45
作者：
BJORNSSON, TD
COCCHETTO, DM
MCGOWAN, FX
VERGHESE, CP
SEDOR, F
机构：
[1] DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA
[2] DUKE UNIV, MED CTR, DEPT CLIN CHEM, DURHAM, NC 27710 USA
来源：
CLINICAL PHARMACOKINETICS | 1983年 / 8卷 / 04期
关键词：
D O I：
10.2165/00003088-198308040-00007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：365 / 369
页数：5
相关论文
共 29 条
[21]   Studies in diseases of muscle I Metabolism of creatine and creatinine in progressive muscular dystrophy [J].
Milhorat, AT ;
Wolff, HG .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1937, 38 (05) :992-1024
[22]   DEVELOPMENT OF RENAL IMPAIRMENT IN LAENNECS CIRRHOSIS [J].
MULLANE, JF ;
GLIEDMAN, ML .
ANNALS OF SURGERY, 1971, 174 (06) :892-+
[23]  
RICHARDS RK, 1978, CLIN PHARMACOL THER, V23, P430
[24]   EFFECT OF AGE ON CREATININE CLEARANCE IN MEN - CROSS-SECTIONAL AND LONGITUDINAL STUDY [J].
ROWE, JW ;
ANDRES, R ;
TOBIN, JD ;
NORRIS, AH ;
SHOCK, NW .
JOURNALS OF GERONTOLOGY, 1976, 31 (02) :155-163
[25]  
ROWLAND M, 1980, CLIN PHARMACOKINET, P230
[26]  
SIERSBAE.K, 1971, LANCET, V1, P1133
[27]   NOMOGRAM FOR MODIFICATION OF DOSAGE REGIMENS IN PATIENTS WITH CHRONIC RENAL-FUNCTION IMPAIRMENT [J].
TOZER, TN .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (01) :13-28
[28]  
WAGNER JG, 1975, FUNDAMENTALS CLIN PH, P158
[29]  
WHEELER LA, 1979, AM J CLIN PATHOL, V72, P27
123